MeSH D002280 - basal cell carcinoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Fluorouracil | Adrucil | 1991-10-18 | |||
| Fluorouracil | Fluorouracil | 2000-01-27 | ||||
| Novast Laboratories | Fluorouracil | Fluorouracil | 2019-12-12 | |||
| Padagis | Imiquimod | Imiquimod | 2010-09-07 | |||
| Taro Pharmaceutical | Fluorouracil | Fluorouracil | 2003-11-05 | |||
| Imiquimod | Imiquimod | 2011-04-15 | ||||
| Glenmark Pharmaceuticals | Imiquimod | Imiquimod | 2012-03-06 | |||
| Rising Pharmaceuticals | Fluorouracil | Fluorouracil | 2015-04-20 | |||
| Sandoz | Fluorouracil | Fluorouracil | 2011-05-02 | |||
| 3M | Imiquimod | Zartra | 1998-09-18 | |||
| Bausch Health Companies | Imiquimod | Aldara | 2024-04-01 | 1997-02-27 | ||
| Fluorouracil | Carac | 2000-10-27 | ||||
| Fluorouracil | Efudex | 1982-01-01 | ||||
| Imiquimod | Zyclara | 2029-08-18 | 2010-03-25 | |||
| Cosette Pharmaceuticals | Imiquimod | Imiquimod | 2011-04-18 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
48%11/23
Phase 2
8%1/13
Phase 3
100%9/9
Approved: 6Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use